20th annual European Pharmaceutical Pricing and Reimbursement

Evaluate HTA Reforms and Market Access Processes to Optimise Business Profit Sponsored by: Quintiles.

13-14 Oct 2014 at London Marriott Hotel Regents Park, United Kingdom

Pharmaceuticals/Drug Discovery

20th annual European Pharmaceutical Pricing and Reimbursement 13-14 Oct 2014 London Marriott Hotel Regents Park, United Kingdom
Submit new post
Thank you for posting.
Share it:

Speakers ({{speakersCount}})

Show all

People (3)

Show all

Market access remains one of the most significant current and future challenges for the industry. Spiralling drug development costs exert pressure to ensure successful and effective planning of your access strategies. With up to $5 billion in R&D costs for every successful drug launched, winning strategies are critical . Understanding the strengths and shortcomings in your people, processes and evidence are going to be the keys to your success. Planning around these key factors will enable increased market share for your organisation.

This year's conference will be held on 13-14 October. Now in its 20th year, this event has been one of the oldest market leaders in the pharmaceutical industries calendar for some time. Our expert speaking faculty; made up from key industry personnel from big pharma, biotech and academia will thoroughly explain and offer advice on P&R and market access. The 2014 agenda will focus on case studies as applied to different countries and environments in terms of market access.

Benefits of Attending:
Evaluate challenges within price discrimination
Implications of AMNOG featuring IGES institut, EUCOPE and Ministry of Health, Germany
Case study from Ipsen on latest developments in pharmaceutical pricing
Analyse the impact of Value Based Assessment on SMEs
Gain further insight on how to engage effectively with payers
Key presentation on the IMI GetReal Consortium
Ample networking opportunities , including a drinks reception on the close of Day One sponsored by Quintiles

Key Speakers:
Leyla Hannbeck, Head of Pharmacy Services, National Pharmacy Association
Silke Baumann, Head of Unit, Pricing, Assessment and Reimbursement of New Medicines, Ministry of Health, Germany
Rodolphe Perard, Associate Director, Market Access, Gilead
Francois Bernard, Head of Market Access, Mundipharma
Mike Chambers, Head of Reimbursement and Value, Market Access and Healthcare Solutions, GlaxoSmithKline
Plus many more..

Standard Rate: £1499
Early bird 1: £1199
Early Bird 2: £1399

From: October 13, 2014 09:00
To: October 14, 2014 19:00

London Marriott Hotel Regents Park, 128 King Henry's Rd, NW3 3ST, United Kingdom


Pharmaceuticals/Drug Discovery

Contact email

Contact phone

External link

Submitted by:

evvnt Platform

Are you the organizer?

Get in touch